NSETrading Window7h ago · 25 Sept 2026, 11:47 am

Trading Window

Shilpa Medicare Limited · SHILPAMED

✦ AI SummaryResults

Shilpa Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shilpa Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

SHILPAMED_25092026114656_Trading_window_notice.pdf

pdf

Download →
View document text
Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 25 September 2026 To To Corporate Relationship Department National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, 1st Floor, Rotunda Building, Plot No.C/1, G Block P.J. Towers, Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400 001. Mumbai – 400 051. Stock Code: BSE – 530549/ NSE – SHILPAMED Dear Sir/Ma’am, Sub: Intimation of Closure of Trading Window Pursuant to the ‘Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company shall remain closed for all the designated persons and their immediate relatives, Connected Persons (including their relatives) as covered under the said Code with effect from 01 October 2026, till 48 hours after the declaration of un-audited Financial Results for quarter and half year ended 30 September 2026. Accordingly, all Designated Persons of the Company are being advised not to trade in the securities of the Company during the aforesaid period of closure of the Trading Window. Please note that the date of the Board Meeting to be held for consideration of the unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026, shall be communicated in due course. This is for your information and records. Thanking you, For Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer